DAJY(SZ:002030)2022-12-08 01:31Group 1: Company Overview - The company is known as Da An Gene Co., Ltd., with the stock code 002030 [1] - The investor relations activity took place on November 5, 2015, from 10:00 AM to 12:00 PM at the company headquarters in Guangzhou [2] Group 2: Hospital Investment Management - The company develops hospital investment management projects through new hospital constructions or mixed reform of existing hospitals [3] - There are no specific location requirements for hospital investments; potential sites are nationwide [3] - The company has three advantages in hospital investment management: 1. Originating from a medical university, it understands hospital systems 2. Being a state-owned enterprise, it is familiar with institutional issues 3. It operates within the pharmaceutical sector, making it a specialized company [3] Group 3: Second-Generation Gene Sequencing - The company has two subsidiaries involved in second-generation gene sequencing: 1. Guangzhou Dary Bio-Technology Co., Ltd., focusing on clinical operations in the field of prenatal and postnatal care 2. An independent laboratory providing testing services [4] - The parent company is engaged in research and development of second-generation gene sequencing, while other subsidiaries depend on specific circumstances [4] - The company is also developing applications of second-generation sequencing technology in oncology, a field that is still maturing in China [4] Group 4: New Three Board Listings - Many subsidiaries have applied for listing on the New Third Board in the past two years to improve their equity structure and achieve financing [4]